|
Overall Morningstar Rating™ |
| What is this? |
 |
 |
| As of 2009-10-31 |
 |
Out of Mid-Cap Growth Funds |
 |
| Rating derived from a weighted average of the fund's 3, 5, 10-year rating which are based on risk-adjusted performance. |
 |
|
 |
Morningstar® Style Box™ |
| What is this? |
 |
 |
|
Small |
|
|
Growth |
|
|
|
 |
|
|
|
 |
| As of
2009-09-30 |
|
 |
| Day Change |
| $ -0.02 |
|
|
| NAV (2009-11-20) |
| $ 11.78 |
|
|
| YTD Return % (2009-11-20) |
| 24.82% |
|
|
| Total Assets ($ mil) |
| 21 |
|
| Growth of $10,000 |
 |
Fund: |
Needham Aggressive Growth |
| (from
2001-09-04
to 2009-10-31) |
 |
Category: |
Mid-Cap Growth |
|
 |
Index: |
S&P 500 TR |
| Total Annualized Returns % |
1yr, 3yr and 5yr Returns as of 2009-11-20 |
| Inception date: 2001-09-04 |
10yr and Inception Returns as of 2009-10-31 |
|
YTD Returns as of 2009-11-20 |
|
|
YTD |
1 Year |
3 Year |
5 Year |
10 Year |
Since Inception |
| Fund |
24.82 |
41.77 |
1.78 |
6.91 |
--- |
6.24 |
| +/- Category |
-0.98 |
25.54 |
7.14 |
5.23 |
--- |
--- |
| +/- S&P 500 TR |
1.30 |
-7.03 |
7.68 |
6.23 |
--- |
--- |
 |
 |
| Standardized Annual Returns % more on standardized returns |
| Quarter-End (as of
2009-09-30) |
26.67 |
7.34 |
5.01 |
8.46 |
--- |
6.92 |
| Month-End (as of 2009-10-31) |
20.95 |
18.03 |
2.03 |
6.99 |
--- |
6.24 |
 |
 |
| After Tax Returns % (as of
2009-09-30
)
|
| On Distribution |
--- |
16.67 |
0.43 |
5.90 |
--- |
--- |
| On Distribution & Sale of Shares |
--- |
13.04 |
1.64 |
5.98 |
--- |
--- |
 |
 |
| Morningstar Rating |
--- |
--- |
 |
 |
--- |
--- |
 |
| # of compared funds covered (3 yrs : out of 749 funds), (5 yrs : out of 636 funds), (10 yrs : out of funds). Ratings are based on risk-adjusted performance. The maximum initial sales fee is
none,
the maximum deferred sales fee is
none,
and the maximum redemption sales fee is
2.00%.
|
 |
| The performance quoted represents past performance and does not guarantee future results. The investment return and principal value of an investment will fluctuate thus an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted herein. |
|
 |
 |
 |
| Sector Breakdown % |
|
 |
Information |
29.76 |
 |
Software |
9.92 |
 |
Hardware |
11.93 |
 |
Media |
0.07 |
 |
Telecommunications |
7.84 |
 |
 |
 |
 |
Service |
63.21 |
 |
Healthcare |
44.13 |
 |
Consumer Services |
13.72 |
 |
Business Services |
3.43 |
 |
Financial Services |
1.92 |
 |
 |
 |
 |
Manufacturing |
7.04 |
 |
Consumer Goods |
2.22 |
 |
Industrial Materials |
4.81 |
 |
Energy |
0.00 |
 |
Utilities |
0.00 |
 |
|
 |
|
| |
|
|
| Asset Allocation |
|
 |
|
| % of Net Assets |
 |
Cash |
21.6 |
 |
Stocks |
78.4 |
 |
Bonds |
0.0 |
 |
Other |
0.0 |
 |
 |
|
Foreign Stocks |
3.4 |
|
(as a % of Assets) |
|
|
| Data through 2009-09-30 |
Data through 2009-09-30 |
 |
| Holding Status |
|
| Total Number of Stock Holdings |
58 |
|
Turnover % |
45 |
| Total Number of Bond Holdings |
0 |
|
30 Day SEC Yield % |
--- |
| % of Assets in Top 10 Holdings |
29.00 |
|
ending as of
2009-09-30 |
|
|
|
|
View Data Definitions |
| Top 10 Holdings |
Sector |
P/E |
YTD Return % |
% of Net Assets |
 |
 |
 |
 |
 |
 |
 |
Dreyfus Treasury Pr Cash Mgmt Inst |
--- |
--- |
--- |
21.59 |
 |
Varian Medical Systems, Inc. |
 |
14.51 |
30.17 |
3.82 |
|
Gilead Sciences, Inc. |
 |
24.33 |
-9.29 |
3.52 |
|
Express Scripts |
 |
17.73 |
54.77 |
3.51 |
 |
Precision Castparts Corp. |
 |
8.00 |
73.66 |
2.82 |
|
 |
|
Apple, Inc. |
 |
15.85 |
134.24 |
2.80 |
 |
NuVasive, Inc. |
 |
--- |
-2.45 |
2.63 |
 |
Actuate Corporation |
 |
14.10 |
39.86 |
2.62 |
 |
Candela Corporation |
 |
--- |
489.80 |
2.49 |
|
Dick's Sporting Goods, Inc. |
 |
11.60 |
52.94 |
2.42 |
|
 |
 |
Data through 2009-09-30 |
| YTD Return through 2009-11-20 |
 |
|
| Fund Inception: 2001-09-04 |
|
Portfolio Manager (Start Date) |
|
|
|
 |
|
Bernard Lirola (2008-01-17) |
|
|
|
Lirola is the Portfolio Manager and Executive Vice President of the Growth Fund and the Aggressive Growth Fund. Prior to joining Needham in 1994, he worked at Smith Barney, Harris Upham & Co. (1976-1978), CS First Boston (1978-1990) and Swiss Bank Corporation (1990-1994). Lirola was an early member of CS First Boston’s M&A group (1978), recruited by Joseph Perella and Bruce Wasserstein and headed CS First Boston’s M&A healthcare group (1985-1990). At Swiss Bank Corporation, he was Head of U.S. M&A activities (1990-1994). Lirola joined Needham in 1994 and was successively a Co-Head of Health Care, Co-Head of Investment Banking and a member of its Operating Committee. Between 1996 and 1999, he was also an equity research analyst covering the health care services industry. His current duties include portfolio management-related activities, including stock selection, research, company visits and market analysis. |
|
|
|
|
Sales Charge % (taken from prospectus dated 2009-08-26) |
| Front: |
None |
| Deferred: |
None |
 |
| Expense Ratio % |
2.50 |
based on net assets
(taken from annual report dated 2008-12-31)
|
|
| Correspondence Information |
445 Park Ave
New York,
NY
10022 USA |
|
|
|
|
|